{"content":"<li class=\"n-box-item date-title\" data-end=\"1508903999\" data-start=\"1508817600\" data-txt=\"Monday, December 23, 2019\">Tuesday, October 24, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3303638\" data-ts=\"1508890156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGC\" target=\"_blank\">RGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303638-regal-entertainment-ceo-talks-moviepass-industry-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regal Entertainment CEO talks MoviePass, industry upside</a></h4><ul><li>Regal Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a>) CEO Amy Miles says the movie theater operator won't share ticket sales or concessions revenue with subscription upstart MoviePass (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>).</li><li>Miles also struck a confident tone on the earnings conference call about the Q4 and 2018 movie slate, seeming to indicate that the up-and-down box office performance of the first three quarters of 2017 is in the past.</li><li>Similar to many consumer-facing companies, Q3 sales fell a bit short of analyst estimates that didn't fully factor in the impact from the U.S. hurricanes in August and September.</li><li>Shares of RGC are&nbsp;<font color='green'>up 3.36%</font>&nbsp;in the AH session. For those keeping score on Helios &amp; Matheson Analytics, shares of the MoviePass owner are&nbsp;<font color='green'>up 1.04% AH</font>&nbsp;after a 6.4% drop in the regular session. A less-than-hostile tone from Miles on MoviePass could be helping.</li><li>IMAX (NYSE:<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a>) and AMC Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a>) also traded higher in the late session following the Regal earnings print.</li><li><a href=\"http://investor.regmovies.com/news-and-events/events-and-presentations\" target=\"_blank\">Regal Entertainment earnings call webcast</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3303532-regal-higher-earnings-topper\" target=\"_blank\">Regal higher after earnings topper</a> (Oct. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303638\" data-linked=\"Regal Entertainment CEO talks MoviePass, industry upside\" data-tweet=\"$RGC $RGC $HMNY - Regal Entertainment CEO talks MoviePass, industry upside https://seekingalpha.com/news/3303638-regal-entertainment-ceo-talks-moviepass-industry-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3303638-regal-entertainment-ceo-talks-moviepass-industry-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303623\" data-ts=\"1508881132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303623-texas-instruments-reports-q3-beats-segment-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Instruments reports Q3 beats, Other segment loss</a></h4><ul><li>Texas Instruments (NYSE:<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a>) shares are&nbsp;<font color='red'>down 1.39%&nbsp;</font>aftermarket following Q3 results with EPS and revenue beats. Q4 outlook puts revenue between $3.57B to $3.87B and EPS from $1.01 to $1.15, compared to the consensus estimates of $3.66B and $1.01, respectively.</li><li>Segment results: Analog revenue was up 16% on the year to $2.7B with a 32% jump in operating profit to $1.3B. Embedded Processing revenue was up 17% to $931M with its operating profit up 45% to $325. The Other segment (DLP products, calculators, and custom ASIC products) revenue fell 13% to $487 and the operating profit fell 14% to $195M.</li><li>Cash flow from operations TTM was $4.8B with FCF at $4.2B or 29% of revenue for the same period. Texas Instruments returned $4.3B to shareholders in the past year through dividends and stock repurchases and announced a new 24% dividend increase and $6B share repurchase program in September. The company ended the quarter with $1.3B in cash and equivalents and $3.1B in long-term debt.</li><li><a href=\"https://seekingalpha.com/pr/16978372-ti-reports-3q17-financial-results-shareholder-returns\" target=\"_blank\">Press release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3303473-texas-instruments-beats-0_12-beats-revenue\" target=\"_blank\">Texas Instruments beats by $0.12, beats on revenue</a> (Oct. 24)</li><li>Correction: Edited headline to better reflect results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303623\" data-linked=\"Texas Instruments reports Q3 beats, Other segment loss\" data-tweet=\"$TXN - Texas Instruments reports Q3 beats, Other segment loss https://seekingalpha.com/news/3303623-texas-instruments-reports-q3-beats-segment-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3303623-texas-instruments-reports-q3-beats-segment-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303620\" data-ts=\"1508881005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303620-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a> <font color='green'>+10.1%</font>. <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='green'>+9.2%</font>. <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='green'>+5.9%</font>. <a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a> <font color='green'>+4.3%</font>. <a href='https://seekingalpha.com/symbol/KRA' title='Kraton Corporation'>KRA</a> <font color='green'>+4.1%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/ACHC' title='Acadia Healthcare Co.'>ACHC</a> <font color='red'>-17.8%</font>. <a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a> <font color='red'>-12.8%</font>. <a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='red'>-10.3%</font>. <a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a> <font color='red'>-9.4%</font>. <a href='https://seekingalpha.com/symbol/SALT' title='Scorpio Bulkers Inc'>SALT</a> <font color='red'>-7.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303620\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AKAM $WLL $IRBT - After Hours Gainers / Losers https://seekingalpha.com/news/3303620-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3303620-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303607\" data-ts=\"1508879704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303607-amd-reports-q3-beats-expects-q-q-revenue-drop-shares-down-10_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD reports Q3 beats but expects Q/Q revenue drop; shares down 10.4%</a></h4><ul><li>        Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) shares are&nbsp;<font color='red'>down 10.39%&nbsp;</font>aftermarket following Q3 EPS and revenue beats. The company expects Q4 revenue to fall between 12% and 18% sequentially, but the midpoint would represent a 26% growth on the year or about $1.4B (consensus: $1.34B).</li><li>               AMD raises its full-year revenue growth guidance from the prior forecast of mid-to-high teens to over 20%.&nbsp;</li><li>               Computing and Graphics revenue was up 74% to $819M primarily due to strong Radeon and Ryzen sales. Client and GPU ASPs &ldquo;increased significantly&rdquo; on the year. Segment operating income was $70M compared to last year&rsquo;s $66M loss.&nbsp;</li><li>               Enterprise, Embedded and Semi-Custom segment revenue was $824M, flat on the year as lower SoC sales were offset by IP and EPYC processor sales. Operating income was $84M, down from $136M last year primarily due to higher costs.&nbsp;</li><li>               Financials: Non-GAAP gross margin was up 4% on the year to 35% with Q4 expected flat on the quarter. AMD ended the quarter with $879M in cash and equivalents and $1.43B in total debt.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16978522-amd-reports-third-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3303607\" data-linked=\"AMD reports Q3 beats but expects Q/Q revenue drop; shares down 10.4%\" data-tweet=\"$AMD - AMD reports Q3 beats but expects Q/Q revenue drop; shares down 10.4% https://seekingalpha.com/news/3303607-amd-reports-q3-beats-expects-q-q-revenue-drop-shares-down-10_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3303607-amd-reports-q3-beats-expects-q-q-revenue-drop-shares-down-10_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>331&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303582\" data-ts=\"1508878317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNSS\" target=\"_blank\">SNSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303582-sunesis-readies-equity-offering-shares-down-17-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunesis readies equity offering; shares down 17% after hours</a></h4><ul><li>Sunesis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a>) launches a <a href=\"https://seekingalpha.com/pr/16978439-sunesis-announces-proposed-public-offering-common-stock-preferred-stock-warrants\" target=\"_blank\">public offering</a> of common stock, convertible preferred stock and warrants. Prices, volumes and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>17%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303582\" data-linked=\"Sunesis readies equity offering; shares down 17% after hours\" data-tweet=\"$SNSS - Sunesis readies equity offering; shares down 17% after hours https://seekingalpha.com/news/3303582-sunesis-readies-equity-offering-shares-down-17-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3303582-sunesis-readies-equity-offering-shares-down-17-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303579\" data-ts=\"1508878072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUVA\" target=\"_blank\">NUVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303579-nuvasive-q3-top-line-up-4-non-gaap-earnings-up-27-shares-down-4-after-hours-on-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuVasive Q3 top line up 4%; non-GAAP earnings up 27%; shares down 4% after hours on revenue miss</a></h4><ul><li>NuVasive (NASDAQ:<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a>) <a href=\"https://seekingalpha.com/pr/16978391-nuvasive-reports-third-quarter-2017-financial-results\" target=\"_blank\">Q3 results </a>($M): 247.4 (+3.7%).</li><li>Net Income: 33.6 (+761.5%): Non-GAAP Net Income: 26.7 (+26.5%); EPS: 0.64 (+814.3); Non-GAAP EPS: 0.52 (+30.0%); CF Ops (9 mo.): 118.9 (+23.9%).</li><li><strong>2017 Guidance</strong>: Revenue: $1.03B from $1.065B; EPS: $1.37 from $1.13; Non-GAAP EPS: $1.91 - 2.00.</li><li>Consensus view was non-GAAP EPS of $0.48 on revenues of $255M.</li><li>Shares are down&nbsp;<font color='red'>4%</font>&nbsp;after hours on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303579\" data-linked=\"NuVasive Q3 top line up 4%; non-GAAP earnings up 27%; shares down 4% after hours on revenue miss\" data-tweet=\"$NUVA - NuVasive Q3 top line up 4%; non-GAAP earnings up 27%; shares down 4% after hours on revenue miss https://seekingalpha.com/news/3303579-nuvasive-q3-top-line-up-4-non-gaap-earnings-up-27-shares-down-4-after-hours-on-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3303579-nuvasive-q3-top-line-up-4-non-gaap-earnings-up-27-shares-down-4-after-hours-on-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303572\" data-ts=\"1508877667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLL\" target=\"_blank\">WLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303572-whiting-petroleum-selects-anadarkos-holly-new-president-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whiting Petroleum selects Anadarko&#39;s Holly as new President/CEO</a></h4><ul>     <li>Whiting Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a>) <font color='green'>+2.3%</font> after-hours as it names Anadarko Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a>) veteran Bradley Holly as its <a href=\"https://seekingalpha.com/pr/16978540-whiting-petroleum-corporation-names-bradley-j-holly-president-chief-executive-officer\" target=\"_blank\">new President and CEO</a>, effective Nov. 1.</li>     <li>Holly worked for APC since 1997, rising to executive VP for U.S. onshore exploration and production this May.</li>     <li>WLL previously had announced the planned retirement of James Volker, who has served as WLL's President and CEO since 2002.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303572\" data-linked=\"Whiting Petroleum selects Anadarko&#39;s Holly as new President/CEO\" data-tweet=\"$WLL $WLL $APC - Whiting Petroleum selects Anadarko&#39;s Holly as new President/CEO https://seekingalpha.com/news/3303572-whiting-petroleum-selects-anadarkos-holly-new-president-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3303572-whiting-petroleum-selects-anadarkos-holly-new-president-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303565\" data-ts=\"1508877386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICE\" target=\"_blank\">ICE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303565-virtu-financial-sells-bondpoint-to-ice-for-400m-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Virtu Financial sells BondPoint to ICE for $400M; shares up 2%</a></h4><ul><li>From the <a href='https://seekingalpha.com/symbol/ICE' title='Intercontinental Exchange, Inc.'>ICE</a> press release: \"BondPoint is a leading provider of electronic fixed income trading solutions for the buy-side and sell-side offering access to centralized liquidity and automated trade execution services through its ATS linking more than 500 financial services firms.\"</li><li>The deal is expected to close in Q1 of 2018.</li><li><a href='https://seekingalpha.com/symbol/VIRT' title='Virtu Financial, Inc.'>VIRT</a>&nbsp;<font color='green'>+2.1%</font>&nbsp;after hours</li><li>Source: <a href=\"https://seekingalpha.com/pr/16978509-intercontinental-exchange-announces-agreement-acquire-virtu-bondpoint\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303565\" data-linked=\"Virtu Financial sells BondPoint to ICE for $400M; shares up 2%\" data-tweet=\"$ICE $ICE $VIRT - Virtu Financial sells BondPoint to ICE for $400M; shares up 2% https://seekingalpha.com/news/3303565-virtu-financial-sells-bondpoint-to-ice-for-400m-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3303565-virtu-financial-sells-bondpoint-to-ice-for-400m-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303553\" data-ts=\"1508877119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKSI\" target=\"_blank\">MKSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303553-mks-instruments-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MKS Instruments beats by $0.10, beats on revenue</a></h4><ul><li>MKS Instruments (NASDAQ:<a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a>): Q3 EPS of $1.56 <font color='green'>beats by $0.10</font>.</li><li>Revenue of $486M (+27.7% Y/Y) <font color='green'>beats by $9.69M</font>.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/16978558-mks-instruments-reports-third-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303553\" data-linked=\"MKS Instruments beats by $0.10, beats on revenue\" data-tweet=\"$MKSI - MKS Instruments beats by $0.10, beats on revenue https://seekingalpha.com/news/3303553-mks-instruments-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303553-mks-instruments-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303552\" data-ts=\"1508877058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EW\" target=\"_blank\">EW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303552-edwards-lifesciences-q3-miss-pressures-shares-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edwards Lifesciences Q3 miss pressures shares, down 7%</a></h4><ul><li>Edwards Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a>) <a href=\"https://seekingalpha.com/pr/16978501-edwards-lifesciences-reports-third-quarter-results\" target=\"_blank\">Q3 results </a>($M): Total Revenues: 821.5 (+11.1%), Transcatheter Heart Valves: 481.2 (+17.3%), Surgical Heart Valves: 195.6 (+2.5%); Critical Care: 144.7 (+4.6%).</li><li>Net Income: 170.1 (+20.3%); Non-GAAP Net Income: 181.8 (+22.6%); EPS: 0.79 (+21.5%); Non-GAAP EPS: 0.84 (+23.5%).</li><li><strong>2017 Guidance</strong>: Revenue: high end of $3.2B - 3.4B; non-GAAP EPS: $3.65 - 3.85.</li><li><strong>Q4 Guidance</strong>: Revenue: $855M - 895M; non-GAAP EPS: $0.84 - 0.94.</li><li>Consensus view was non-GAAP EPS of $0.86 on revenues of $832M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303552\" data-linked=\"Edwards Lifesciences Q3 miss pressures shares, down 7%\" data-tweet=\"$EW - Edwards Lifesciences Q3 miss pressures shares, down 7% https://seekingalpha.com/news/3303552-edwards-lifesciences-q3-miss-pressures-shares-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3303552-edwards-lifesciences-q3-miss-pressures-shares-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303550\" data-ts=\"1508877028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303550-juniper-networks-slides-6_7-on-downbeat-q4-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper Networks slides 6.7% on downbeat Q4 guidance</a></h4><ul>   <li>Juniper Networks (<a href=\"http://seekingalpha.com/symbol/JNPR\" target=\"_blank\">JNPR</a> <font color='green'>+1.6%</font>) has <font color='red'>slid 6.7%</font> after hours following a <a href=\"https://seekingalpha.com/news/3303522-juniper-networks-eps-revenue-line\" target=\"_blank\">Q3 earnings report</a> that was mostly in line but guided low, pointing to deployment timing delays in the fourth quarter.</li>    <li>Revenues fell 2% Y/Y and were down 4% from the prior quarter; adjusted profits fell 5% Y/Y and 4% sequentially, to $211.1M.</li>    <li>\"While we are disappointed in our third quarter revenue results which were impacted by timing of switching deployments, we have made significant progress on executing on our cloud strategy,\" says CEO Rami Rahim.</li>    <li>Revenue breakout: Product, $869.7M (down 6.3%); Service, $388.1M (up 8.7%).</li>   <li>Product revenue by segment: Routing, $585.8M (down 5.5%); Switching, $212.6M (down 4.5%); Security, $71.3M (down 16.6%).</li>   <li>Overall revenue by vertical: Cloud, $344.9M (down 4%); Telecom/Cable, $576.9M (down 3.8%); Strategic Enterprise, $336M (up 2.9%).</li>    <li>The company's Q4 outlook \"reflects continued large deployment timing delays as Juniper expects its large customers to continue their architectural transition.\"</li>    <li>It sees gross margins remaining at current levels, and forecasts Q4 revenues of $1.2B-$1.26B, below consensus for $1.33B, and non-GAAP EPS of $0.49-$0.55, below expectations for $0.60.</li>    <li><a href=\"http://investor.juniper.net/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16978486-juniper-networks-reports-preliminary-third-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3303550\" data-linked=\"Juniper Networks slides 6.7% on downbeat Q4 guidance\" data-tweet=\"$JNPR - Juniper Networks slides 6.7% on downbeat Q4 guidance https://seekingalpha.com/news/3303550-juniper-networks-slides-6_7-on-downbeat-q4-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3303550-juniper-networks-slides-6_7-on-downbeat-q4-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303544\" data-ts=\"1508876779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303544-akamai-reports-q3-beats-cloud-security-and-web-growth-sharesplus-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai reports Q3 beats, Cloud Security and Web growth; shares +3.5%</a></h4><ul><li>        Akamai (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) shares are&nbsp;<font color='green'>up 3.45%</font>&nbsp;aftermarket following a Q3 report with EPS and revenue beats.</li><li>               Division revenue (adjusted for foreign exchange): Web, $328M (+14% Y/Y); Media, $273M (-1%); Enterprise and Carrier, $20M (+2%).&nbsp;</li><li>               Solution revenue (adjusted): Performance and Security Solutions, $381M (+10%); Cloud Security Solutions $121M (+27%); Media Delivery Solutions, $183M (-3%); Services and Support Solutions, $57M (+12%).&nbsp;</li><li>               Other revenue: U.S. sales accounted for $409M, up 1% on the year, while International revenue grew 18% to $213M. Revenue from Internet Platform Customers was $51M, down 13%.&nbsp;&nbsp;</li><li>               Key financials: Non-GAAP income from operations was $142M, down 13%, with a 5 percentage point drop in operating margin to 23%.&nbsp; Cash from operations totaled $236M or 38% of total revenue. The company spent $129M to repurchase 2.7M shares during the period. Akamai had $1.4B in cash and equivalents at the end of the quarter.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16978388-akamai-reports-third-quarter-2017-financial-results\" target=\"_blank\">Press release </a>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303479-akamai-beats-0_03-beats-revenue\" target=\"_blank\">Akamai beats by $0.03, beats on revenue</a> (Oct. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303544\" data-linked=\"Akamai reports Q3 beats, Cloud Security and Web growth; shares +3.5%\" data-tweet=\"$AKAM - Akamai reports Q3 beats, Cloud Security and Web growth; shares +3.5% https://seekingalpha.com/news/3303544-akamai-reports-q3-beats-cloud-security-and-web-growth-sharesplus-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3303544-akamai-reports-q3-beats-cloud-security-and-web-growth-sharesplus-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303533\" data-ts=\"1508876435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SALT\" target=\"_blank\">SALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303533-scorpio-bulkers-to-launch-10m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scorpio Bulkers to launch 10M-share offering</a></h4><ul><li>Scorpio Bulkers (NYSE:<a href='https://seekingalpha.com/symbol/SALT' title='Scorpio Bulkers Inc'>SALT</a>) <font color='red'>-12.6%</font> after-hours as it commences a <a href=\"https://seekingalpha.com/pr/16978438-scorpio-bulkers-inc-announces-public-offering-common-shares\" target=\"_blank\">public offering</a> of 10M common shares, with an underwriters option to purchase up to an additional 1.5M shares.</li><li>SALT says it plans to use the proceeds for general corporate purposes, which may include the expansion of its fleet of drybulk carriers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303533\" data-linked=\"Scorpio Bulkers to launch 10M-share offering\" data-tweet=\"$SALT - Scorpio Bulkers to launch 10M-share offering https://seekingalpha.com/news/3303533-scorpio-bulkers-to-launch-10m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3303533-scorpio-bulkers-to-launch-10m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303532\" data-ts=\"1508876423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGC\" target=\"_blank\">RGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303532-regal-higher-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regal higher after earnings topper</a></h4><ul>     <li>Regal Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a>) reports attendance fell 14% to 44.69M patrons in <a href=\"https://seekingalpha.com/pr/16978460-regal-entertainment-group-reports-results-third-quarter-2017-declares-quarterly-dividend\" target=\"_blank\">Q3.</a></li><li>Higher ticket prices and average concession spending helped make up some of the difference as total revenue fell 12% during the quarter. The company also peeled back on film rental and advertising costs.</li><li>\"In a challenging third quarter box office environment, we were pleased that our ongoing focus on customer amenities had a positive impact on our market share and operating metrics,\" says CEO Regal CEO Amy Miles.</li><li>Will anyone on the conference call ask Regal execs about the impact of MoviePass?</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303506-regal-entertainment-beats-0_02-beats-revenue\" target=\"_blank\">Regal Entertainment beats by $0.02, beats on revenue</a> (Oct. 24)</li><li>Shares of Regal are up 5.20% in AH trading to $17.20.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303532\" data-linked=\"Regal higher after earnings topper\" data-tweet=\"$RGC - Regal higher after earnings topper https://seekingalpha.com/news/3303532-regal-higher-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3303532-regal-higher-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303531\" data-ts=\"1508876370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KRA\" target=\"_blank\">KRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303531-kraton-beats-0_57-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kraton beats by $0.57, beats on revenue</a></h4><ul><li>Kraton (NYSE:<a href='https://seekingalpha.com/symbol/KRA' title='Kraton Corporation'>KRA</a>): Q3 EPS of $1.51 <font color='green'>beats by $0.57</font>.</li><li>Revenue of $510.9M (+12.5% Y/Y) <font color='green'>beats by $29.13M</font>.</li><li>Shares <font color='green'>+6.2%</font>.</li><li><a href='https://seekingalpha.com/pr/16978453-kraton-corporation-announces-third-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303531\" data-linked=\"Kraton beats by $0.57, beats on revenue\" data-tweet=\"$KRA - Kraton beats by $0.57, beats on revenue https://seekingalpha.com/news/3303531-kraton-beats-0_57-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303531-kraton-beats-0_57-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303525\" data-ts=\"1508876255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COF\" target=\"_blank\">COF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303525-capital-one-up-1_9-after-topping-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital One up 1.9% after topping estimates</a></h4><ul><li>Q3 adjusted EPS of $2.42 vs. $1.90 earned in Q3 one year ago. Adjusting items include more than $200M or $0.28 per share from the Cabela's deal and restructuring charges.</li><li>The company also saw an impact from the hurricanes of $114M or $0.15 per share, as well as a benefit of $69M or $0.09 per share from gains on investment portfolio repositioning.</li><li>Credit loss provisions up 2% for the quarter to $1.8B.</li><li>Net interest margin of 7.08% up 20 basis points.</li><li>Period-end loans up 3% to $252.4B, with card loans up 8% to $100B, auto loans up 3% to $53.3B, and home loans down 5% to $$18.8B.</li><li><a href=\"http://www.capitalone.com\" target=\"_blank\">Earnings call at 5 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3303501-capital-one-financial-beats-0_27-beats-revenue\" target=\"_blank\">Capital One Financial beats by $0.27, beats on revenue</a> (Oct. 24)</li><li><a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a>&nbsp;<font color='green'>+1.9%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3303525\" data-linked=\"Capital One up 1.9% after topping estimates\" data-tweet=\"$COF - Capital One up 1.9% after topping estimates https://seekingalpha.com/news/3303525-capital-one-up-1_9-after-topping-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3303525-capital-one-up-1_9-after-topping-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303521\" data-ts=\"1508876153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMP\" target=\"_blank\">AMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303521-ameriprise-financial-beats-0_73-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ameriprise Financial beats by $0.73, misses on revenue</a></h4><ul><li>Ameriprise Financial (NYSE:<a href='https://seekingalpha.com/symbol/AMP' title='Ameriprise Financial, Inc.'>AMP</a>): Q3 EPS of $3.53 <font color='green'>beats by $0.73</font>.</li><li>Revenue of $2.98B (-0.7% Y/Y) <font color='red'>misses by $10M</font>.</li><li>Shares <font color='green'>+1.64%</font>.</li><li><a href='https://seekingalpha.com/pr/16978463-ameriprise-financial-reports-third-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303521\" data-linked=\"Ameriprise Financial beats by $0.73, misses on revenue\" data-tweet=\"$AMP - Ameriprise Financial beats by $0.73, misses on revenue https://seekingalpha.com/news/3303521-ameriprise-financial-beats-0_73-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303521-ameriprise-financial-beats-0_73-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303504\" data-ts=\"1508875897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303504-chipotle-limps-in-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle limps in with Q3 results</a></h4><ul>     <li>Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) reports comparable sales increased 1.0% in <a href=\"https://seekingalpha.com/pr/16978418-chipotle-third-quarter-diluted-eps-increased-155-percent-8_8-percent-revenue-growth\" target=\"_blank\">Q3</a> vs. +1.2% consensus estimate.</li>     <li>Restaurant-level operating margin jumped to 16.1% vs. 14.1% a year ago.</li><li>Labor costs fell 40 bps to 27.2% of sales.</li>     <li>Food/beverage/packaging costs as a percentage of sales fell 10 bps to 35.0%.</li>     <li>G&amp;A expenses were up 120 bps to 8.8% of sales.</li>          <li>Chipotle says it expects comparable restaurant sales to increase 6.5% in 2017, consistent with prior guidance. The company expects to open in the low end of its prior guidance for 195 and 210 new restaurants this year. 130 to 150 new openings are anticipated for 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303492-chipotle-mexican-grill-misses-0_17-misses-revenue\" target=\"_blank\">Chipotle Mexican Grill misses by $0.17, misses on revenue</a> (Oct. 24)</li>          <li>CMG&nbsp;<font color='red'>-4.46%&nbsp;</font>AH to $310.01.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303504\" data-linked=\"Chipotle limps in with Q3 results\" data-tweet=\"$CMG - Chipotle limps in with Q3 results https://seekingalpha.com/news/3303504-chipotle-limps-in-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3303504-chipotle-limps-in-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>131&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303501\" data-ts=\"1508875831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COF\" target=\"_blank\">COF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303501-capital-one-financial-beats-0_27-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital One Financial beats by $0.27, beats on revenue</a></h4><ul><li>Capital One Financial (NYSE:<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a>): Q3 EPS of $2.42 <font color='green'>beats by $0.27</font>.</li><li>Revenue of $6.99B (+8.2% Y/Y) <font color='green'>beats by $180M</font>.</li><li>Shares <font color='green'>+1.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16978454-capital-one-reports-third-quarter-2017-net-income-1_1-billion-2_14-per-share'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303501\" data-linked=\"Capital One Financial beats by $0.27, beats on revenue\" data-tweet=\"$COF - Capital One Financial beats by $0.27, beats on revenue https://seekingalpha.com/news/3303501-capital-one-financial-beats-0_27-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303501-capital-one-financial-beats-0_27-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303498\" data-ts=\"1508875791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFLT\" target=\"_blank\">PFLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303498-pennantpark-floating-rate-capital-raise-shares-down-1_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PennantPark Floating Rate capital raise; shares down 1.3%</a></h4><ul><li>The company is selling 6M shares of common stock, with underwriter greenshoe of 900K shares.</li><li>PennantPark's (NASDAQ:<a href='https://seekingalpha.com/symbol/PFLT' title='PennantPark Floating Rate Capital'>PFLT</a>) investment advisor will pay a portion of the underwriting fee.</li><li>Shares&nbsp;<font color='red'>-1.3%</font>&nbsp;after hours</li><li>Source: <a href=\"https://seekingalpha.com/pr/16978441-pennantpark-floating-rate-capital-ltd-announces-public-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303498\" data-linked=\"PennantPark Floating Rate capital raise; shares down 1.3%\" data-tweet=\"$PFLT - PennantPark Floating Rate capital raise; shares down 1.3% https://seekingalpha.com/news/3303498-pennantpark-floating-rate-capital-raise-shares-down-1_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3303498-pennantpark-floating-rate-capital-raise-shares-down-1_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303497\" data-ts=\"1508875761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MANH\" target=\"_blank\">MANH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303497-manhattan-associates-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manhattan Associates beats by $0.02, beats on revenue</a></h4><ul><li>Manhattan Associates (NASDAQ:<a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a>): Q3 EPS of $0.51 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $152.88M (+0.4% Y/Y) <font color='green'>beats by $2.57M</font>.</li><li>Shares <font color='green'>+2%</font>.</li><li><a href='https://seekingalpha.com/pr/16978446-manhattan-associates-reports-solid-third-quarter-performance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303497\" data-linked=\"Manhattan Associates beats by $0.02, beats on revenue\" data-tweet=\"$MANH - Manhattan Associates beats by $0.02, beats on revenue https://seekingalpha.com/news/3303497-manhattan-associates-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303497-manhattan-associates-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303491\" data-ts=\"1508875651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ILMN\" target=\"_blank\">ILMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303491-illumina-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illumina beats by $0.12, beats on revenue</a></h4><ul><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>): Q3 EPS of $1.11 <font color='green'>beats by $0.12</font>.</li><li>Revenue of $714M (+17.6% Y/Y) <font color='green'>beats by $20.73M</font>.</li><li>Shares <font color='green'>+1.9%</font>.</li><li><a href='https://seekingalpha.com/pr/16978434-illumina-reports-financial-results-third-quarter-fiscal-year-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303491\" data-linked=\"Illumina beats by $0.12, beats on revenue\" data-tweet=\"$ILMN - Illumina beats by $0.12, beats on revenue https://seekingalpha.com/news/3303491-illumina-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303491-illumina-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303488\" data-ts=\"1508875585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDRA\" target=\"_blank\">IDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303488-idera-launches-equity-offering-shares-down-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idera launches equity offering; shares down 8% after hours</a></h4><ul><li>Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) readies a $60M <a href=\"https://seekingalpha.com/pr/16978371-idera-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be announced. Net proceeds will fund the advancement of IMO-2125, working capital and general corporate purposes.</li><li>Shares are down&nbsp;<font color='red'>8%&nbsp;</font>after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303488\" data-linked=\"Idera launches equity offering; shares down 8% after hours\" data-tweet=\"$IDRA - Idera launches equity offering; shares down 8% after hours https://seekingalpha.com/news/3303488-idera-launches-equity-offering-shares-down-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3303488-idera-launches-equity-offering-shares-down-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303484\" data-ts=\"1508875535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303484-irobot-beats-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">iRobot beats by $0.13, beats on revenue</a></h4><ul><li>iRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>): Q3 EPS of $0.60 <font color='green'>beats by $0.13</font>.</li><li>Revenue of $205.4M (+21.8% Y/Y) <font color='green'>beats by $0.88M</font>.</li><li>Shares <font color='green'>+7.81%</font>.</li><li><a href='https://seekingalpha.com/pr/16978384-irobot-reports-strong-third-quarter-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303484\" data-linked=\"iRobot beats by $0.13, beats on revenue\" data-tweet=\"$IRBT - iRobot beats by $0.13, beats on revenue https://seekingalpha.com/news/3303484-irobot-beats-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303484-irobot-beats-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303479\" data-ts=\"1508875386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303479-akamai-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai beats by $0.03, beats on revenue</a></h4><ul><li>Akamai (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>): Q3 EPS of $0.62 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $621.4M (+6.4% Y/Y) <font color='green'>beats by $10.71M</font>.</li><li>Shares <font color='green'>+4%</font>.</li><li><a href='https://seekingalpha.com/pr/16978388-akamai-reports-third-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303479\" data-linked=\"Akamai beats by $0.03, beats on revenue\" data-tweet=\"$AKAM - Akamai beats by $0.03, beats on revenue https://seekingalpha.com/news/3303479-akamai-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303479-akamai-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303465\" data-ts=\"1508874291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303465-piper-defends-lilly-says-selloff-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper defends Lilly, says selloff overdone</a></h4><ul><li>Piper Jaffray says today's down move in Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-2.4%</font>) is \"clear buying opportunity\" considering its attractive long-term growth prospects. Analyst Richard Purkiss believes investor fears are \"overblown\" after management stated that it does intend to challenge Sanofi's (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color='red'>-1.3%</font>) Humalog (insulin lispro injection) biosimilar. He adds that the company's potential spinout of its animal health business makes sense (Overweight/$107).</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3303465\" data-linked=\"Piper defends Lilly, says selloff overdone\" data-tweet=\"$LLY $LLY $SNY - Piper defends Lilly, says selloff overdone https://seekingalpha.com/news/3303465-piper-defends-lilly-says-selloff-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3303465-piper-defends-lilly-says-selloff-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303461\" data-ts=\"1508873772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303461-fda-action-date-today-for-ptc-therapeutics-filing-over-protest-nda-for-dmd-med-translarna\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA action date today for PTC Therapeutics&#39; &quot;filing over protest&quot; NDA for DMD med Translarna; shares down 5%</a></h4><ul><li>Investors are sending a clear signal that they do not expect good news today from the FDA regarding PTC Therapeutics' (<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-4.6%</font>) New Drug Application &#40;NDA&#41; seeking approval for Translarna (ataluren) for the treatment of Duchenne muscular dystrophy &#40;DMD&#41;. Today is the agency's action date under \"filing under protest\" regulations.&nbsp;Last month, an advisory committee voted 10 - 1 that the efficacy data supporting the application was inconclusive.</li><li>Shares have sold off more than&nbsp;<font color='green'>22%</font>&nbsp;this month.</li><li>Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='red'>-4.7%</font>), maker of DMD med EXONDYS 51 (eteplirsen), is also under pressure ahead of tomorrow's Q3 earnings report.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248775-fda-review-ptcs-marketing-application-dmd-candidate-translarna-protest-regulations-action\" target=\"_blank\">FDA to review PTC's marketing application for DMD candidate Translarna under protest regulations; action date October 24; shares ahead 15% premarket</a> (March 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3298268-fda-ad-com-says-data-ptcs-translarna-inclusive-needed-prove-efficacy\" target=\"_blank\">FDA Ad Com says data on PTC's Translarna inclusive, more needed to prove efficacy</a> (Sept. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303461\" data-linked=\"FDA action date today for PTC Therapeutics&#39; &quot;filing over protest&quot; NDA for DMD med Translarna; shares down 5%\" data-tweet=\"$PTCT $PTCT $SRPT - FDA action date today for PTC Therapeutics&#39; &quot;filing over protest&quot; NDA for DMD med Translarna; shares down 5% https://seekingalpha.com/news/3303461-fda-action-date-today-for-ptc-therapeutics-filing-over-protest-nda-for-dmd-med-translarna?source=tweet\" data-url=\"https://seekingalpha.com/news/3303461-fda-action-date-today-for-ptc-therapeutics-filing-over-protest-nda-for-dmd-med-translarna\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303462\" data-ts=\"1508873579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VISI\" target=\"_blank\">VISI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303462-volt-infoplus-60-after-selling-quality-assurance-testing-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volt Info +60% after selling quality assurance testing business</a></h4><ul>     <li>Volt Information Systems (<a href='https://seekingalpha.com/symbol/VISI' title='Volt Information Sciences, Inc.'>VISI</a> <font color='green'>+61.4%</font>) soars ~60% after <a href=\"https://seekingalpha.com/pr/16977047-volt-information-sciences-enters-agreement-sell-quality-assurance-testing-unit-vmc-66_4\" target=\"_blank\">agreeing to sell</a> its quality assurance testing unit to Keywords International for $66.4M.</li><li>The business provides       production development, QA testing and customer support to companies       primarily in the video gaming and mobile industries.</li>     <li>Volt says the sale of the non-core assets, which represent ~5% of its global revenue, will allow it to become a pure-play       staffing company.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303462\" data-linked=\"Volt Info +60% after selling quality assurance testing business\" data-tweet=\"$VISI $VOLT - Volt Info +60% after selling quality assurance testing business https://seekingalpha.com/news/3303462-volt-infoplus-60-after-selling-quality-assurance-testing-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3303462-volt-infoplus-60-after-selling-quality-assurance-testing-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303456\" data-ts=\"1508871592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HES\" target=\"_blank\">HES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303456-bloomberg-hess-deal-flurry-sacrifices-steady-revenue-for-chance-of-future-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Hess deal flurry sacrifices steady revenue for chance of future growth</a></h4><ul>     <li>With $2.7B in oilfield sales this week (<a href=\"https://seekingalpha.com/news/3303167-aker-bp-buy-norway-unit-hess\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/news/3303043-kosmos-energy-buys-hess-stakes-equatorial-guinea-offshore-oilfields\" target=\"_blank\">II</a>), Hess (<a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color='red'>-2.9%</font>) is making a calculated bet, giving up steady production today to help fund the promise of future growth from what could be one of the world&rsquo;s biggest oil discoveries, <a href=\"https://www.bloomberg.com/news/articles/2017-10-24/hess-building-a-war-chest-with-4-4-billion-guyana-find-in-mind\" target=\"_blank\">writes Bloomberg's Alex Nussbaum</a>.</li>     <li>Hess is building a war chest to help develop a discovery off the coast of Guyana in South America that may hold 2.5B boe; Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='green'>+0.3%</font>), its partner in the project, has said the initial building phase may cost $4.4B and take until 2020 to deliver its first oil, but the payoff could mean more than a decade of growth for shareholders.</li>     <li>The divestments &ldquo;all make strategic sense\" and &ldquo;will help bridge the sizable funding gap that Hess faces over the next few years,\" says Capital One Securities analyst Phillips Johnston, while adding that the company is giving up operations that produced 16% of its total oil volumes and almost 25% of its EBITDA.</li>     <li>Hess had telegraphed its North Sea sales, so investors may have discounted some of the gains, says Cowen's Charles Robertson, adding that the total sales proceeds are more than Hess's projected share of the Guyana project and some may question whether the company is selling too much.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303456\" data-linked=\"Bloomberg: Hess deal flurry sacrifices steady revenue for chance of future growth\" data-tweet=\"$HES $HES $XOM - Bloomberg: Hess deal flurry sacrifices steady revenue for chance of future growth https://seekingalpha.com/news/3303456-bloomberg-hess-deal-flurry-sacrifices-steady-revenue-for-chance-of-future-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3303456-bloomberg-hess-deal-flurry-sacrifices-steady-revenue-for-chance-of-future-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303453\" data-ts=\"1508871549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTD\" target=\"_blank\">AMTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303453-td-ameritrade-holds-3-gain-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TD Ameritrade holds 3% gain after earnings</a></h4><ul><li>The company topped estimates, and provided fiscal 2018 guidance of $2.10-$2.50 - the midpoint well ahead of the $2.13 estimate from Jefferies' Daniel Fannon.</li><li>Helping are Scottrade synergies, with the company still seeing $450M of savings, but now expecting to hit 40% of that in year one vs. 25% previously.</li><li>Speaking to Bloomberg, CEO Tim Hockey says investor engagement remains strong despite low volatility. The bull market, says Hockey, seems \"long in the tooth.\"</li><li><a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a> currently&nbsp;<font color='green'>higher by 3.15%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303284-td-ameritrade-3_3-percent-earnings-beat-2018-outlook\" target=\"_blank\">TD Ameritrade up 3.3% after earnings beat, 2018 outlook</a> (Oct. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303453\" data-linked=\"TD Ameritrade holds 3% gain after earnings\" data-tweet=\"$AMTD - TD Ameritrade holds 3% gain after earnings https://seekingalpha.com/news/3303453-td-ameritrade-holds-3-gain-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3303453-td-ameritrade-holds-3-gain-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303452\" data-ts=\"1508871322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303452-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TESS' title='TESSCO Technologies Incorporated'>TESS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CVLT' title='CommVault Systems, Inc.'>CVLT</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303452\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$TESS $APDN $SMIT - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3303452-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303452-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303448\" data-ts=\"1508870523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303448-caterpillarplus-5-after-blowing-expectations-out-of-water\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar +5% after blowing expectations out of the water</a></h4><ul>     <li>Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+4.9%</font>) surges 5% after crushing <a href=\"https://seekingalpha.com/news/3303262-caterpillar-crushes-estimates-boosts-outlook\" target=\"_blank\">Q3 earnings</a> estimates and <a href=\"http://www.reuters.com/article/us-caterpillar-results/caterpillar-smashes-wall-street-estimates-as-north-america-sales-rebound-idUSKBN1CT1LT?il=0\" target=\"_blank\">raising its full-year forecast</a> for sales and earnings, expecting revenue in its construction business to jump ~20% and mining business to surge 30%.</li>     <li>\"Results were <a href=\"http://www.chicagotribune.com/business/ct-biz-caterpillar-earnings-20171024-story.html\" target=\"_blank\">better than expected across the board</a>, with construction, mining, energy all strong,\" says Edward Jones analyst Matt Arnold. The growth in energy and transport \"has a nice impact on earnings given the fact that this business carries higher margins.\"</li>     <li>\"<a href=\"http://www.marketwatch.com/story/caterpillars-big-bet-on-china-may-finally-be-paying-off-2017-10-24\" target=\"_blank\">China continues to be a bright spot</a> and a surprise to the upside,\" CFO&nbsp;Brad Halverson said in today's earnings conference call. \"Our current estimate for 2017 is for the 10-ton-and-above excavator industry in China to more than double vs. last year, which would result in sales that are higher than our estimate of normal replacement demand for the region.\"</li>     <li>A couple of analysts weigh in with <a href=\"http://www.barrons.com/articles/caterpillar-is-shedding-its-cyclical-shackles-1508867416\" target=\"_blank\">higher stock price targets</a>: Melius Research ups its 2018 EPS estimate to $7.50 from $7.10 and bumps its stock price target to $172 from $168, saying \"there may be further outperformance as revenues cycle up to mid, with overshoot likely,\" and CFRA hikes its price target to $180 from $140, seeing the company as \"well positioned for an improving global economy, with significant operating leverage on accelerating top-line growth.\"</li>     <li>But others wonder if CAT can sustain such high growth rates; Steve Volkmann at Jefferies says &ldquo;sustainability of the scorching pace of growth Caterpillar set in the latest quarter is in question because construction spending in the country has not yet hit an inflection point.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303448\" data-linked=\"Caterpillar +5% after blowing expectations out of the water\" data-tweet=\"$CAT - Caterpillar +5% after blowing expectations out of the water https://seekingalpha.com/news/3303448-caterpillarplus-5-after-blowing-expectations-out-of-water?source=tweet\" data-url=\"https://seekingalpha.com/news/3303448-caterpillarplus-5-after-blowing-expectations-out-of-water\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303444\" data-ts=\"1508868053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303444-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/USEG' title='U.S. Energy Corp.'>USEG</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CLB' title='Core Laboratories'>CLB</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NSU' title='Nevsun Resources Ltd.'>NSU</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/XCO' title='EXCO Resources, Inc.'>XCO</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303444\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$USEG $RCON $IPI - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3303444-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303444-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303635\" data-ts=\"1508867839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USEG\" target=\"_blank\">USEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303635-u-s-energyplus-31-after-unveiling-upcoming-drilling-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Energy +31% after unveiling upcoming drilling program</a></h4><ul>     <li>U.S. Energy (<a href='https://seekingalpha.com/symbol/USEG' title='U.S. Energy Corp.'>USEG</a> <font color='green'>+31.7%</font>) surges after announcing plans to <a href=\"https://seekingalpha.com/pr/16976747-u-s-energy-corp-announces-participation-upcoming-drilling-program\" target=\"_blank\">participate in up to six horizontal wells</a> on its existing acreage position.</li>     <li>USEG says the horizontal drilling program with CML Exploration will target the Georgetown formation in southern Texas at a cost of ~$3.4M per well; at current commodity prices, single well economics are expected to generate a ~60% internal rate of return, 2.5x cash on cash return and pay back in  about a year.</li>     <li>Drilling costs will be funded from cash flow from operations and existing cash on hand, the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303635\" data-linked=\"U.S. Energy +31% after unveiling upcoming drilling program\" data-tweet=\"$USEG - U.S. Energy +31% after unveiling upcoming drilling program https://seekingalpha.com/news/3303635-u-s-energyplus-31-after-unveiling-upcoming-drilling-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3303635-u-s-energyplus-31-after-unveiling-upcoming-drilling-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303441\" data-ts=\"1508867012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATOS\" target=\"_blank\">ATOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303441-atossa-spikes-ahead-of-preliminary-data-on-endoxifen-shares-ahead-95\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atossa spikes ahead of preliminary data on endoxifen; shares ahead 95%</a></h4><ul><li>Nano cap Atossa Genetics (<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='green'>+95.2%</font>) rockets on a 16x surge in volume ahead of tomorrow's conference call (10:00 am ET) to discuss preliminary results from its Phase 1 dose-escalation study of oral cancer med endoxifen.</li><li>Endoxifen is an active metabolite of tamoxifen, the active ingredient in AstraZeneca's Nolvadex (the company stopped making it in June 2006).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295516-atossas-topical-breast-cancer-candidate-endoxifen-performs-well-early-stage-study-shares\" target=\"_blank\">Atossa's topical breast cancer candidate endoxifen performs well in early-stage study; shares ahead 21%</a> (Sept. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303441\" data-linked=\"Atossa spikes ahead of preliminary data on endoxifen; shares ahead 95%\" data-tweet=\"$ATOS - Atossa spikes ahead of preliminary data on endoxifen; shares ahead 95% https://seekingalpha.com/news/3303441-atossa-spikes-ahead-of-preliminary-data-on-endoxifen-shares-ahead-95?source=tweet\" data-url=\"https://seekingalpha.com/news/3303441-atossa-spikes-ahead-of-preliminary-data-on-endoxifen-shares-ahead-95\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303438\" data-ts=\"1508866637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303438-big-pharma-biotech-players-under-pressure-valeant-only-bright-spot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big pharma/biotech players under pressure, Valeant only bright spot</a></h4><ul><li>The big players in pharmaceuticals and biotech are not faring too well today, Valeant Pharmaceuticals (VRX <font color='green'>+1.7%</font>) being the exception.</li><li>Biogen, Lilly and Novartis reported quarterly earnings this morning. All three beat consensus but Biogen posted less-than-expected Spinraza sales in the U.S., Lilly is mulling strategic alternatives for its Elanco Animal Health unit and Novartis is delaying spinning off Alcon.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/IHE' title='iShares U.S. Pharmaceuticals ETF'>IHE</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/PPH' title='VanEck Vectors Pharmaceutical ETF'>PPH</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-3.1%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-2.8%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='red'>-3.1%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-3.6%</font>)(<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='red'>-0.3%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303438\" data-linked=\"Big pharma/biotech players under pressure, Valeant only bright spot\" data-tweet=\"$BHC $BHC $IHE - Big pharma/biotech players under pressure, Valeant only bright spot https://seekingalpha.com/news/3303438-big-pharma-biotech-players-under-pressure-valeant-only-bright-spot?source=tweet\" data-url=\"https://seekingalpha.com/news/3303438-big-pharma-biotech-players-under-pressure-valeant-only-bright-spot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303439\" data-ts=\"1508866229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303439-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/IBN' title='ICICI Bank Ltd.'>IBN</a> <font color='green'>+8%</font>.<a href='https://seekingalpha.com/symbol/CIA' title='Citizens, Inc.'>CIA</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/BBX' title='BBX Capital Corp.'>BBX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='green'>+8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303439\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$PN $IBN $CIA - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3303439-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303439-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303437\" data-ts=\"1508865962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWW\" target=\"_blank\">GWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303437-industrial-distributors-lower-after-amazon-business-prime-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Industrial distributors lower after Amazon Business Prime launch</a></h4><ul><li>It's already been a tough year for most of the group as investors pondered the threat from e-commerce. That threat becomes more real today after <a href=\"https://seekingalpha.com/news/3303406-amazon-launches-business-prime-shipping-new-kindle-app\" target=\"_blank\">Amazon launches</a> Business Prime Shipping.</li><li>WW Grainger (<a href='https://seekingalpha.com/symbol/GWW' title='W.W. Grainger, Inc.'>GWW</a> <font color='red'>-3.5%</font>), MSC Industrial (<a href='https://seekingalpha.com/symbol/MSM' title='MSC Industrial Direct Co. Inc.'>MSM</a> <font color='red'>-2.7%</font>), Fastenal (<a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color='red'>-3.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303437\" data-linked=\"Industrial distributors lower after Amazon Business Prime launch\" data-tweet=\"$GWW $GWW $MSM - Industrial distributors lower after Amazon Business Prime launch https://seekingalpha.com/news/3303437-industrial-distributors-lower-after-amazon-business-prime-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/3303437-industrial-distributors-lower-after-amazon-business-prime-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303433\" data-ts=\"1508864350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VECO\" target=\"_blank\">VECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303433-keybanc-downgrades-veeco-shares-down-over-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc downgrades Veeco; shares down over 12%</a></h4><ul><li>        KeyBanc Capital Markets <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10218055/veecos-core-business-faces-a-triple-threat-market-slowd\" target=\"_blank\">downgrades</a> Veeco Instruments (NASDAQ:<a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a>) from Overweight to Sector Weight.</li><li>               Analysts Daniel Baksht and Weston Twigg cite MOCVD performance concerns raised during competitor and supplier checks.&nbsp;</li><li>               The analysts say the price-competitive MOCVD market and release of newer products could have a sustainable negative impact on Veeco shares. Margin upside also appears hard to achieve.&nbsp;</li><li>Veeco shares are&nbsp;<font color='red'>down 12.18%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3285504-veeco-instruments-beats-0_11-beats-revenue\" target=\"_blank\">Veeco Instruments beats by $0.11, beats on revenue</a> (Aug. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303433\" data-linked=\"KeyBanc downgrades Veeco; shares down over 12%\" data-tweet=\"$VECO - KeyBanc downgrades Veeco; shares down over 12% https://seekingalpha.com/news/3303433-keybanc-downgrades-veeco-shares-down-over-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3303433-keybanc-downgrades-veeco-shares-down-over-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303431\" data-ts=\"1508864306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303431-early-stage-study-underway-for-molecular-templates-blood-cancer-candidate-mtminus-3724-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Early-stage study underway for Molecular Templates&#39; blood cancer candidate MT-3724; shares up 2%</a></h4><ul><li>Thinly traded micro cap Molecular Templates (<a href='https://seekingalpha.com/symbol/MTEM' title='Molecular Templates, Inc.'>MTEM</a> <font color='green'>+1.8%</font>) is up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16977541-molecular-templates-announces-dosing-first-patient-phase-1-expansion-study-mtminus-3724\" target=\"_blank\">announcement </a>that the first patient has been dosed in a Phase 1 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02715843?term=NCT02715843&amp;rank=1\" target=\"_blank\">expansion study</a> assessing lead candidate MT-3724 in up to 40 patients with diffuse large B-cell lymphoma &#40;DLBCL&#41;. Results should be available in H1 2018.</li><li>A (potential) pivotal Phase 2 study in treatment-resistant DLBCL will commence in 2018.</li><li>MT-3724 is an immunotoxin that targets the cancer cell surface antigen CD20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303431\" data-linked=\"Early-stage study underway for Molecular Templates&#39; blood cancer candidate MT-3724; shares up 2%\" data-tweet=\"$MTEM - Early-stage study underway for Molecular Templates&#39; blood cancer candidate MT-3724; shares up 2% https://seekingalpha.com/news/3303431-early-stage-study-underway-for-molecular-templates-blood-cancer-candidate-mtminus-3724-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3303431-early-stage-study-underway-for-molecular-templates-blood-cancer-candidate-mtminus-3724-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303429\" data-ts=\"1508863917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303429-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers /Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VISI' title='Volt Information Sciences, Inc.'>VISI</a> <font color='green'>+61%</font>. <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+43%</font>. <a href='https://seekingalpha.com/symbol/SSKN' title='STRATA Skin Sciences, Inc'>SSKN</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/USEG' title='U.S. Energy Corp.'>USEG</a> <font color='green'>+31%</font>. LTEA <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BGI' title='Birks Group Inc.'>BGI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CONN' title='Conn&#39;s, Inc.'>CONN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/TESS' title='TESSCO Technologies Incorporated'>TESS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/PII' title='Polaris Industries Inc.'>PII</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/NAUH' title='National American University Holdings, Inc.'>OTC:NAUH</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303429\" data-linked=\"Midday Gainers /Losers\" data-tweet=\"$VOLT $SAVA $SSKN - Midday Gainers /Losers https://seekingalpha.com/news/3303429-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3303429-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303428\" data-ts=\"1508863729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YNDX\" target=\"_blank\">YNDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303428-yandexplus-7_5-after-boosting-guidance-in-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yandex +7.5% after boosting guidance in Q3 report</a></h4><ul>   <li>Yandex (NASDAQ:<a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a>) is <font color='green'>up 7.5%</font> and inched fractionally close to its 52-week high after <a href=\"https://seekingalpha.com/symbol/YNDX/news\" target=\"_blank\">Q3 earnings</a> that missed expectations but contained raised revenue guidance.</li>    <li>The company now sees ruble-based revenue growth at 22-23% for fiscal 2017.</li>    <li>Revenues overall grew 21% in ruble terms to 23.4B rubles, essentially in line with expectations; Ex-TAC, revenues rose 22% to 19.03B rubles. Net income, though, fell 65% to 0.9B rubles, and EBITDA fell 17% to 5.7B rubles.</li>    <li>In operational metrics, the company's share of the Russian search market averaged 54.9%, up from last quarter's 54.3%, and hit 55.5% in September. Queries grew 7% Y/Y.</li>    <li>Meanwhile, paid clicks on Yandex and partner sites were up 6% Y/Y and average cost per click went up 12%.</li>    <li>Cash, equivalents and term deposits were 66.6B rubles (about $1.15B) as of Sept. 30.</li>    <li><a href=\"https://seekingalpha.com/pr/16977004-yandex-announces-third-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3303428\" data-linked=\"Yandex +7.5% after boosting guidance in Q3 report\" data-tweet=\"$YNDX - Yandex +7.5% after boosting guidance in Q3 report https://seekingalpha.com/news/3303428-yandexplus-7_5-after-boosting-guidance-in-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3303428-yandexplus-7_5-after-boosting-guidance-in-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303426\" data-ts=\"1508863155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303426-cellectar-bio-finalizes-design-of-multiple-dose-fifth-cohort-in-early-stage-dose-escalation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio finalizes design of multiple dose fifth cohort in early-stage dose-escalation study of multiple myeloma candidate CLR 131; shares ahead 2%</a></h4><ul><li>Thinly traded nano cap Cellectar Biosciences (<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+2.4%</font>) perks up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16977473-cellectar-biosciences-introduces-multiple-dose-regimen-fifth-cohort-phase-1-trial-clr-131\" target=\"_blank\">announcement </a>of the design of the multiple dose fifth cohort in its Phase 1 dose-escalation safety study of lead candidate CLR 131 in treatment-resistant multiple myeloma.</li><li>Cohort 5 will receive two 15.625 mCi/m2 doses one week apart. The total dose of 31.25 mCI/m2 is the same total dose as Cohort 4 which produced a partial response. In all previous cohorts CLR 131 was administered in a single infusion.</li><li>The dose will be split in Cohort 5 based on the recommendation by the independent Data Monitoring Committee that the regimen may be advantageous.</li><li>CLR 131 is a&nbsp;<a href=\"http://cellectar.com/pdc-platform/\" target=\"_blank\">phospholipid ether-drug conjugate</a>&nbsp;that selectively delivers a cytotoxic payload to cancer cells.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297906-cellectars-clr-131-shows-positive-action-highest-dose-early-stage-multiple-myeloma-study\" target=\"_blank\">Cellectar's CLR 131 shows positive action at highest dose in early-stage multiple myeloma study</a> (Sept. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303426\" data-linked=\"Cellectar Bio finalizes design of multiple dose fifth cohort in early-stage dose-escalation study of multiple myeloma candidate CLR 131; shares ahead 2%\" data-tweet=\"$CLRB - Cellectar Bio finalizes design of multiple dose fifth cohort in early-stage dose-escalation study of multiple myeloma candidate CLR 131; shares ahead 2% https://seekingalpha.com/news/3303426-cellectar-bio-finalizes-design-of-multiple-dose-fifth-cohort-in-early-stage-dose-escalation?source=tweet\" data-url=\"https://seekingalpha.com/news/3303426-cellectar-bio-finalizes-design-of-multiple-dose-fifth-cohort-in-early-stage-dose-escalation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303410\" data-ts=\"1508861124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303410-citron-still-bearish-on-mimedx-says-new-research-supports-alleged-dubious-product\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron still bearish on MiMedx, says new research supports alleged dubious product distribution; shares down over 16% in two days</a></h4><ul><li>Embattled MiMedx (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a> <font color='red'>-5%</font>) is under pressure again today on 67% higher volume. Shares have slumped over&nbsp;<font color='red'>16%</font>&nbsp;the past two days as short seller Citron Research doubles down on its bearish view that shares are headed to $3 (74% downside risk).</li><li>In a <a href=\"https://www.youtube.com/watch?v=kVafBagmNg0\" target=\"_blank\">YouTube video</a>, he says new research affirms that the company has employed dubious distributors in order to goose sales.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3296871-mimedx-responding-sec-subpoena-related-whistleblower-allegations-says-revenue-recognition\" target=\"_blank\">MiMedx responding to SEC subpoena related to whistleblower allegations, says revenue recognition policies proper</a> (Sept. 21)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3296723-mimedx-responds-allegations-channel-stuffing-conference-call-tomorrow-update-investors\" target=\"_blank\">MiMedx responds (again) to allegations of channel stuffing; conference call tomorrow to update investors</a> (Sept. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303410\" data-linked=\"Citron still bearish on MiMedx, says new research supports alleged dubious product distribution; shares down over 16% in two days\" data-tweet=\"$MDXG - Citron still bearish on MiMedx, says new research supports alleged dubious product distribution; shares down over 16% in two days https://seekingalpha.com/news/3303410-citron-still-bearish-on-mimedx-says-new-research-supports-alleged-dubious-product?source=tweet\" data-url=\"https://seekingalpha.com/news/3303410-citron-still-bearish-on-mimedx-says-new-research-supports-alleged-dubious-product\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303408\" data-ts=\"1508860838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303408-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> LTEA <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PII' title='Polaris Industries Inc.'>PII</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/KNL' title='Knoll, Inc.'>KNL</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/OI' title='Owens-Illinois, Inc.'>OI</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303408\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$LBCC $PII $KNL - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3303408-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303408-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303406\" data-ts=\"1508860455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303406-amazon-launches-business-prime-shipping-new-kindle-app\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon launches Business Prime Shipping, new Kindle app</a></h4><ul><li>           Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>)<a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=176060&amp;p=irol-newsArticle&amp;ID=2310766\" target=\"_blank\"> launches</a> Business Prime Shipping, an annual membership for multi-user business customers in the U.S. and Germany. </li><li> U.S. customers can receive free two-day shipping on eligible items for all users on the Amazon Business account. </li><li>           Customers can sign-up for a 30-day free trial and then the pricing is tiered accord to user numbers: up to 10, $499; up to 100, $1,299; over 100, $10,099. &nbsp; </li><li>           Amazon also <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=176060&amp;p=irol-newsArticle&amp;ID=2310712\" target=\"_blank\">launches</a> a new Kindle app through the Apple App Store and Google Play. </li><li> The iOS version includes a deeper integration with book recommendation social network Goodreads. </li><li>           Amazon shares are&nbsp;<font color='green'>up 1.38%</font>.&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3303332-amazon-loses-another-studio-executive\" target=\"_blank\">Amazon loses another studio executive</a> (Oct. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303406\" data-linked=\"Amazon launches Business Prime Shipping, new Kindle app\" data-tweet=\"$AMZN - Amazon launches Business Prime Shipping, new Kindle app https://seekingalpha.com/news/3303406-amazon-launches-business-prime-shipping-new-kindle-app?source=tweet\" data-url=\"https://seekingalpha.com/news/3303406-amazon-launches-business-prime-shipping-new-kindle-app\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303404\" data-ts=\"1508860380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENLC\" target=\"_blank\">ENLC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303404-enlink-midstream-advances-ubs-upgrades-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnLink Midstream advances as UBS upgrades to Buy</a></h4><ul>     <li>EnLink Midstream (<a href='https://seekingalpha.com/symbol/ENLC' title='EnLink Midstream, LLC'>ENLC</a> <font color='green'>+1.6%</font>) is higher after UBS <a href=\"https://timesofindia.indiatimes.com/business/international-business/enlink-midstream-llc-advances-on-ubs-upgrade-to-buy/articleshow/61207370.cms\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $19 price target following the recent selloff, as it believes ENLC's 16% interest in Oklahoma Tall Oak is   underappreciated.</li>     <li>The firm foresees a 37% jump in profit in ENLC's Oklahoma segment for 2018 due to expected rig growth and well completions.</li>     <li>UBS says most investors tend to view the earnings direction of EnLink Midstream Partners (<a href='https://seekingalpha.com/symbol/ENLK' title='EnLink Midstream Partners, LP'>ENLK</a> <font color='green'>+0.3%</font>) as the key driver of ENLC, and the firm estimates Oklahoma Tall Oak will represent ~11% of 2017 distributable cash flow; however, UBS expects the number to rise to ~19% in 2018, likely a reason why the firm's estimated 2018 ENLC DCF is ~3% above consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303404\" data-linked=\"EnLink Midstream advances as UBS upgrades to Buy\" data-tweet=\"$ENLC $ENLC $ENLK - EnLink Midstream advances as UBS upgrades to Buy https://seekingalpha.com/news/3303404-enlink-midstream-advances-ubs-upgrades-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3303404-enlink-midstream-advances-ubs-upgrades-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303395\" data-ts=\"1508858831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATEC\" target=\"_blank\">ATEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303395-alphatec-registers-100m-mixed-shelf-offering-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphatec registers $100M mixed shelf offering; shares down 3%</a></h4><ul><li>Alphatec Holdings (<a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='red'>-3.4%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1350653/000119312517317460/d479108ds3.htm\" target=\"_blank\">files an S-3</a> for a $100M mixed shelf offering. The company says the specific uses of net proceeds will be detailed in a prospectus supplement associated with a particular offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303395\" data-linked=\"Alphatec registers $100M mixed shelf offering; shares down 3%\" data-tweet=\"$ATEC - Alphatec registers $100M mixed shelf offering; shares down 3% https://seekingalpha.com/news/3303395-alphatec-registers-100m-mixed-shelf-offering-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3303395-alphatec-registers-100m-mixed-shelf-offering-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303390\" data-ts=\"1508858284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303390-ge-down-another-1_5-analysts-pile-in-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE down another 1.5% as more analysts pile in with downgrades</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-1.5%</font>) extends <a href=\"https://seekingalpha.com/news/3302820-ge-moves-lower-downgrades\" target=\"_blank\">yesterday's shellacking</a> that sent shares to their worst one-day loss in six years following fresh downgrades by Morgan Stanley and UBS; shares are now -30% YTD and are at their lowest levels since early 2013.</li>     <li>Today brings two more downgrades, with Oppenheimer <a href=\"https://thefly.com/thestreet/realmoney/index.php/GEid2627635/GE-General-Electric-downgraded-to-Underperform-at-Oppenheimer\" target=\"_blank\">cutting GE to Underperform</a> from Perform as it sees free cash flow yield insufficient to establish a conviction floor on the shares at current levels.</li>     <li>Stifel <a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Downgrades+General+Electric+%28GE%29+to+Hold%2C+Dividend+Cut+Likely/13414950.html\" target=\"_blank\">downgrades shares to Hold</a> from Buy and lowers its price target to $22 from $26, driven by the substantially reduced expectations for <a href=\"https://seekingalpha.com/news/3302670-ge-ceo-flannery-says-cash-flow-horrible-new-normal\" target=\"_blank\">$7B in Industrial cash flow from operations</a> for 2017 and ~$10B in 2018; given this scenario, Stifel thinks GE will implement a dividend cut to $0.45 from $0.96, which would imply stock support at ~$22 on an assumed dividend yield in-line with S&amp;P 500 at ~2%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303390\" data-linked=\"GE down another 1.5% as more analysts pile in with downgrades\" data-tweet=\"$GE - GE down another 1.5% as more analysts pile in with downgrades https://seekingalpha.com/news/3303390-ge-down-another-1_5-analysts-pile-in-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3303390-ge-down-another-1_5-analysts-pile-in-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303389\" data-ts=\"1508858136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNDR\" target=\"_blank\">SNDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303389-earnings-cheer-lifts-trucking-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Earnings cheer lifts trucking sector</a></h4><ul> <li>There are strong gains in the trucking sector after favorable earnings reports from GM, Caterpillar, PACCAR and Polaris underpin enthusiasm for the level of activity in the industry.</li> <li>Notable gainers include Schneider National (<a href='https://seekingalpha.com/symbol/SNDR' title='Schneider National'>SNDR</a> <font color='green'>+3.8%</font>), USA Truck (<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a> <font color='green'>+3.6%</font>), ArcBest (<a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a> <font color='green'>+1.7%</font>), P.A.M. Transportation Services (<a href='https://seekingalpha.com/symbol/PTSI' title='P.A.M. Transportation Services, Inc.'>PTSI</a> <font color='green'>+2.4%</font>), Celadon Group (<a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a> <font color='green'>+2.3%</font>), Covenant Transportation (<a href='https://seekingalpha.com/symbol/CVTI' title='Covenant Transportation Group, Inc.'>CVTI</a> <font color='green'>+1.1%</font>) and YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color='green'>+0.2%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3303389\" data-linked=\"Earnings cheer lifts trucking sector\" data-tweet=\"$SNDR $SNDR $USAK - Earnings cheer lifts trucking sector https://seekingalpha.com/news/3303389-earnings-cheer-lifts-trucking-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3303389-earnings-cheer-lifts-trucking-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303387\" data-ts=\"1508857737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303387-biogens-u-s-spinraza-sales-short-of-consensus-shares-down-6-licensor-ionis-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen&#39;s U.S. Spinraza sales short of consensus; shares down 6%; licensor Ionis down 11%</a></h4><ul><li>Biogen's (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-6%</font>) Q3 beat was not enough to fend off sellers who ran for the exits after U.S. SPINRAZA (nusinersen) fell short of consensus.</li><li>Total SPINRAZA sales in Q3 were $271M, almost 9% above consensus of $249M, but U.S. sales were $197.6M, over 18% shy of <a href=\"https://www.reuters.com/article/us-biogen-results/biogen-beats-profit-estimates-but-sales-of-spinraza-disappoint-idUSKBN1CT1HM\" target=\"_blank\">consensus of $242M</a>.</li><li>Nusinersen licensor Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-11%</font>) is also down.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303307-biogen-q3-revenues-4-percent-non-gaap-eps-22-percent-shares-3-percent-premarket\" target=\"_blank\">Biogen Q3 revenues up 4%; non-GAAP EPS up 22%; shares off 3% premarket</a> (Oct. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303387\" data-linked=\"Biogen&#39;s U.S. Spinraza sales short of consensus; shares down 6%; licensor Ionis down 11%\" data-tweet=\"$BIIB $BIIB $IONS - Biogen&#39;s U.S. Spinraza sales short of consensus; shares down 6%; licensor Ionis down 11% https://seekingalpha.com/news/3303387-biogens-u-s-spinraza-sales-short-of-consensus-shares-down-6-licensor-ionis-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3303387-biogens-u-s-spinraza-sales-short-of-consensus-shares-down-6-licensor-ionis-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303386\" data-ts=\"1508857565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNRO\" target=\"_blank\">MNRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303386-monro-muffler-swings-lower-after-cutting-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monro Muffler swings lower after cutting profit guidance</a></h4><ul> <li>Monro Muffler (<a href='https://seekingalpha.com/symbol/MNRO' title='Monro, Inc.'>MNRO</a> <font color='red'>-2.3%</font>) sets full-year profit guidance below the expectations of analysts.</li> <li>The auto retailer sees FY17 EPS of $1.95 to $2.10 vs. $2.05 to $2.20 prior view and $2.13 consensus off of comparable sales growth of -1% to +1%.</li> <li>Shares of Monro Muffler are down 14.4% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303386\" data-linked=\"Monro Muffler swings lower after cutting profit guidance\" data-tweet=\"$MNRO - Monro Muffler swings lower after cutting profit guidance https://seekingalpha.com/news/3303386-monro-muffler-swings-lower-after-cutting-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3303386-monro-muffler-swings-lower-after-cutting-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303352\" data-ts=\"1508857236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303352-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+60%</font>. <a href='https://seekingalpha.com/symbol/SSKN' title='STRATA Skin Sciences, Inc'>SSKN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303352\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$SAVA $SSKN $CNCE - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3303352-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3303352-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303381\" data-ts=\"1508856833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303381-10-year-yield-tops-2_40-for-first-time-since-may\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">10-year yield tops 2.40% for first time since May</a></h4><ul><li>The post-Labor Day move higher in interest rates continues, with the 10-year Treasury yield up 3.5 basis points to 2.404%. The year's high in the 10-year yield was 2.62% set back in March. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-0.6%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+1.2%</font></li><li>Banks are welcoming not just the higher rates, but the steeper yield curve, with the SPDR KBW Bank ETF (<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> <font color='green'>+0.7%</font>) topping the S&amp;P 500's&nbsp;<font color='green'>0.1% advance</font>.</li><li>The broader financial sector (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+0.7%</font>) is outperforming as well.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303381\" data-linked=\"10-year yield tops 2.40% for first time since May\" data-tweet=\"$TLT $TBT $KBE - 10-year yield tops 2.40% for first time since May https://seekingalpha.com/news/3303381-10-year-yield-tops-2_40-for-first-time-since-may?source=tweet\" data-url=\"https://seekingalpha.com/news/3303381-10-year-yield-tops-2_40-for-first-time-since-may\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303380\" data-ts=\"1508856799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXE\" target=\"_blank\">AXE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303380-on-anixters-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Anixter&#39;s Q3</a></h4><ul><li>Anixter (<a href='https://seekingalpha.com/symbol/AXE' title='Anixter International Inc.'>AXE</a> <font color='red'>-6.2%</font>)&nbsp;reports organic net sales rose 1.5% in <a href=\"https://seekingalpha.com/pr/16977035-anixter-international-inc-reports-third-quarter-2017-results\" target=\"_blank\">Q3</a>.</li><li>Network &amp; Security Solutions net sales flat Y/Y at&nbsp; $1.05B.</li><li>Electrical &amp; Electronic Solutions net sales grew 3.7% to $555M.</li><li>Utility Power Solutions net sales up 11% to $412.2M.</li><li>North America net sales expanded 0.9% to $1.67B.</li><li>Gross margin rate fell 60 bps to 19.7%, due to customer, product and segment mix.</li><li>Adjusted operating margin rate up 50 bps to 4.5%.</li><li>Adjusted EBITDA margin -40 bps to 5.1%.</li><li>The company expects Q4 organic sales growth in the 2.5% - 3.5% range.</li><li><b>FY2017 Guidance</b>: Organic sales: +3% to +3.5%; Cash flow from operation: $200M to $220M; Capex: $45M to $50M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303380\" data-linked=\"More on Anixter&#39;s Q3\" data-tweet=\"$AXE - More on Anixter&#39;s Q3 https://seekingalpha.com/news/3303380-on-anixters-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3303380-on-anixters-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303378\" data-ts=\"1508856199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDU\" target=\"_blank\">EDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303378-on-new-oriental-education-technologys-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on New Oriental Education &amp; Technology&#39;s Q1</a></h4><ul><li>New Oriental Education &amp; Technology (<a href='https://seekingalpha.com/symbol/EDU' title='New Oriental Education & Technology Group Inc.'>EDU</a> <font color='red'>-4.4%</font>) reports&nbsp;Educational programs and services revenue rose 22.3% to $604.5M in <a href=\"https://seekingalpha.com/pr/16976949-new-oriental-announces-results-first-fiscal-quarter-ended-august-31-2017\" target=\"_blank\">Q1</a>, mainly driven by increases in student enrollments in academic subjects tutoring and test preparation courses in the recent two quarters.</li><li>Books and others revenue grew 42.6% to $56.69M..</li><li>K-12 after-school tutoring business revenue up 35.3% Y/Y.</li><li>Total student enrollments grew 15.6% Y/Y to ~1,532,900.</li><li>The total number of schools and learning centers +128 Y/Y to 899.</li><li>Operating margin rate squeezed 390 bps to 24.8%.</li><li><b>Q2 Guidance</b>: Total net revenues: $447M to $460.7M (+31% to +35% Y/Y).</li></ul><div class=\"tiny-share-widget\" data-id=\"3303378\" data-linked=\"More on New Oriental Education &amp; Technology&#39;s Q1\" data-tweet=\"$EDU - More on New Oriental Education &amp; Technology&#39;s Q1 https://seekingalpha.com/news/3303378-on-new-oriental-education-technologys-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3303378-on-new-oriental-education-technologys-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303376\" data-ts=\"1508855347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PUBGY\" target=\"_blank\">PUBGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303376-ad-stocks-plumbing-multi-year-lows-after-ipg-earnings-disappointment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad stocks plumbing multi-year lows after IPG earnings disappointment</a></h4><ul>   <li>Ad agency stocks are lower following Interpublic Group (<a href=\"http://seekingalpha.com/symbol/IPG\" target=\"_blank\">IPG</a> <font color='red'>-6.2%</font>) on the way down after IPG posted disappointing earnings that it linked to declining industry trends.</li>    <li>IPG shares are at their lowest point in a couple of years. Publicis Groupe (<a href='https://seekingalpha.com/symbol/PUBGY' title='Publicis Groupe S.A. ADR'>OTCQX:PUBGY</a>), which also posted earnings that were a letdown this quarter, is <font color='red'>2.8% lower</font>. Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) is <font color='red'>off 1.9%</font> and at its lowest point in a year and a half.</li>    <li>WPP (WPPGY), meanwhile, is <font color='red'>down 3.2%</font> to four-year lows.</li>    <li>\"Organic revenue was negatively impacted by broader trends that are being felt throughout much of the industry,\" IPG chief Michael Roth said in his <a href=\"https://seekingalpha.com/news/3303356-interpublic-group-minus-5_4-percent-q3-earnings-miss-firm-revises-outlook\" target=\"_blank\">company's earnings report</a>, adding that \"client caution\" prompted a revision to its full-year outlook.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303376\" data-linked=\"Ad stocks plumbing multi-year lows after IPG earnings disappointment\" data-tweet=\"$PUBGY $PUBGY $OMC - Ad stocks plumbing multi-year lows after IPG earnings disappointment https://seekingalpha.com/news/3303376-ad-stocks-plumbing-multi-year-lows-after-ipg-earnings-disappointment?source=tweet\" data-url=\"https://seekingalpha.com/news/3303376-ad-stocks-plumbing-multi-year-lows-after-ipg-earnings-disappointment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303371\" data-ts=\"1508855027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303371-tailored-brandsplus-14-on-positive-comments-from-exec\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tailored Brands +14% on positive comments from exec</a></h4><ul> <li>Tailored Brands (NYSE:<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a>) <font color='green'>soars 14.2%</font> after a top exec with The Men's Wearhouse tells <a href=\"http://www.mr-mag.com/tailored-clothing-menswear-bright-spot/\" target=\"_blank\">MR Magazine</a> that the business has turned positive in the last six weeks (h/t Bloomberg).</li> <li>Scott Norris says the turnaround arrived even with very warm weather in September and October.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3303371\" data-linked=\"Tailored Brands +14% on positive comments from exec\" data-tweet=\"$TLRD - Tailored Brands +14% on positive comments from exec https://seekingalpha.com/news/3303371-tailored-brandsplus-14-on-positive-comments-from-exec?source=tweet\" data-url=\"https://seekingalpha.com/news/3303371-tailored-brandsplus-14-on-positive-comments-from-exec\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303369\" data-ts=\"1508854856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABG\" target=\"_blank\">ABG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303369-on-asbury-automotive-groups-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Asbury Automotive Group&#39;s Q3</a></h4><ul><li>Asbury Automotive Group (<a href='https://seekingalpha.com/symbol/ABG' title='Asbury Automotive Group, Inc.'>ABG</a> <font color='green'>+0.4%</font>)&nbsp;reports total revenues on same-store basis declined 3% in <a href=\"https://seekingalpha.com/pr/16977113-asbury-automotive-group-announces-third-quarter-2017-financial-results\" target=\"_blank\">Q3</a>.</li><li>New vehicles revenue down 6% to $881.6M.</li><li>Used vehicles revenue fell 4% to $455.6M.</li><li>Parts and service revenue slipped 2% to $197.2M.</li><li>Finance and insurance, net revenue increased 4% to $67.7M.</li><li>Gross margin rate improved 40 bps to 16.2%.</li><li>Adjusted operating margin rate +10 bps to 4.4%.</li><li>Total new vehicle unit sales decreased 6% Y/Y to 25,187M.</li><li>Total used vehicle retail units sales -6% to 18,777M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303369\" data-linked=\"More on Asbury Automotive Group&#39;s Q3\" data-tweet=\"$ABG - More on Asbury Automotive Group&#39;s Q3 https://seekingalpha.com/news/3303369-on-asbury-automotive-groups-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3303369-on-asbury-automotive-groups-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303363\" data-ts=\"1508854136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PII\" target=\"_blank\">PII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303363-robust-guidance-takes-polaris-to-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Robust guidance takes Polaris to 52-week high</a></h4><ul> <li>Polaris (<a href='https://seekingalpha.com/symbol/PII' title='Polaris Industries Inc.'>PII</a> <font color='green'>+10.8%</font>) pops after the company <a href=\"https://seekingalpha.com/pr/16976988-polaris-reports-2017-third-quarter-results\" target=\"_blank\">lifted</a> its 2017 revenue forecast to 18% to 19% growth vs. +12% to 14% prior forecast and +15% consensus. Shares hit a new 52-week high of $118.38 before peeling back a bit.</li> <li>The powersports vehicle manufacturer expects full-year EPS of $4.75 to $4.85 vs. $4.35 to $4.50 prior view and $4.50 consensus.</li> <li>'Strong retail growth in both North America and nearly all of our International markets drove record sales and highlighted our ongoing product innovation, improving product quality and sharpened execution,\" notes Polaris CEO Scott Wine.</li> <li>The strong Polaris numbers may be helping to lift sentiment on Thor Industries (<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+1.1%</font>) and Winnebago (<a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color='green'>+2.1%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303363\" data-linked=\"Robust guidance takes Polaris to 52-week high\" data-tweet=\"$PII $PII $THO - Robust guidance takes Polaris to 52-week high https://seekingalpha.com/news/3303363-robust-guidance-takes-polaris-to-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3303363-robust-guidance-takes-polaris-to-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303358\" data-ts=\"1508853508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPD\" target=\"_blank\">RPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303358-needham-initiates-rapid7-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham initiates Rapid7 with Buy rating</a></h4><ul><li>        Needham <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171024075132RPD\" target=\"_blank\">initiates</a> Rapid7 (NASDAQ:<a href='https://seekingalpha.com/symbol/RPD' title='Rapid7'>RPD</a>) with a Buy rating and $23 price target.</li><li>               Firm says Rapid7 is delivering over 25% growth and margin expansions at a steep discount to competing security companies.&nbsp;</li><li>               Needham focuses on the Vulnerability Management category that&rsquo;s positioned to benefit from a shift from hardware-based, on-premise perimeter defense to a data platform-driven model.&nbsp;</li><li>               Rapid7 shares are&nbsp;<font color='green'>up 1.08%.</font>&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3303358\" data-linked=\"Needham initiates Rapid7 with Buy rating\" data-tweet=\"$RPD - Needham initiates Rapid7 with Buy rating https://seekingalpha.com/news/3303358-needham-initiates-rapid7-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3303358-needham-initiates-rapid7-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303357\" data-ts=\"1508853260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCAR\" target=\"_blank\">PCAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303357-on-paccars-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on PACCAR&#39;s Q3</a></h4><ul>     <li>PACCAR (<a href='https://seekingalpha.com/symbol/PCAR' title='PACCAR Inc.'>PCAR</a> <font color='red'>-2.4%</font>)&nbsp;reports trucks sales rose 22% to $3.87B in <a href=\"https://seekingalpha.com/pr/16977265-paccar-achieves-excellent-quarterly-revenues-earnings\" target=\"_blank\">Q3</a>.</li>     <li>Parts revenue up 9.8% to $840M.</li>     <li>Financial services revenue increased 10.8% to $328.2M.</li>     <li>U.S. and Canada revenue grew 23.5% to $3.21B</li>     <li>Revenue for Europe soar 12.6% $1.24B.</li>     <li>New truck deliveries +15.2% Y/Y to 40,200.</li>     <li>Truck, Parts and Other gross margin rate fell 20 bps to 14.5%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303357\" data-linked=\"More on PACCAR&#39;s Q3\" data-tweet=\"$PCAR - More on PACCAR&#39;s Q3 https://seekingalpha.com/news/3303357-on-paccars-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3303357-on-paccars-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303356\" data-ts=\"1508853136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303356-interpublic-groupminus-5_4-q3-earnings-miss-firm-revises-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpublic Group -5.4% as Q3 earnings miss, firm revises outlook</a></h4><ul>   <li>Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) is <font color='red'>5.4% lower</font>, and at two-year lows, out of today's open after <a href=\"https://seekingalpha.com/news/3303233-interpublic-group-companies-misses-0_02-misses-revenue\" target=\"_blank\">Q3 earnings</a> missed on top and bottom lines.</li>    <li>Revenue fell 1% as reported but rose 0.5% on an organic basis; EPS adjusted for below-the-line items was flat Y/Y at $0.31.</li>    <li>It's revised full-year targets for operating margin expansion (40 basis points) and organic revenue growth at 1-2%.</li>    <li>\"Results in the quarter reflect strong operating margin expansion, although organic revenue was negatively impacted by broader trends that are being felt throughout much of the industry,\" says Chairman/CEO Michael Roth, adding that \"client caution\" spurred the company to trim outlook.</li>    <li>Revenue breakout: United States, $1.156B (down 0.8%); International, $746.6M (down 1.3%).</li>    <li><a href=\"http://investors.interpublic.com/phoenix.zhtml?c=87867&amp;p=irol-newsArticle&amp;ID=2310601\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3303356\" data-linked=\"Interpublic Group -5.4% as Q3 earnings miss, firm revises outlook\" data-tweet=\"$IPG - Interpublic Group -5.4% as Q3 earnings miss, firm revises outlook https://seekingalpha.com/news/3303356-interpublic-groupminus-5_4-q3-earnings-miss-firm-revises-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3303356-interpublic-groupminus-5_4-q3-earnings-miss-firm-revises-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303353\" data-ts=\"1508853083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303353-anthera-prices-private-stock-offering-1_25-shares-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera prices private stock offering at $1.25; shares down 10%</a></h4><ul><li>Thinly traded nano cap Anthera Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='red'>-10.2%</font>) slumps on increased volume in reaction to its <a href=\"https://seekingalpha.com/pr/16977467-anthera-pharmaceuticals-announces-pricing-15-million-private-placement-offering\" target=\"_blank\">private placement </a>of stock and warrants in two closings.</li><li>The first involves the direct sale of ~2.3M shares of common stock, each with an accompanying 5 1/2-year warrant to purchase three shares of common at $1.55, at $1.25 per share. Closing date is October 26.</li><li>The second involves the direct sale of ~7.625M shares of common at $1.25 plus ~2.1M shares of non-voting Class Y Preferred Stock at $1.25, convertible into the same number of common shares subject to conditions. Each Class Y share will be issued with an immediately exercisable warrant to purchase one share of common at $1.25.</li><li>Gross proceeds should be ~$15M. Net proceeds will fund the continued development of SOLLPURA, manufacturing and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303353\" data-linked=\"Anthera prices private stock offering at $1.25; shares down 10%\" data-tweet=\"$ANTH - Anthera prices private stock offering at $1.25; shares down 10% https://seekingalpha.com/news/3303353-anthera-prices-private-stock-offering-1_25-shares-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3303353-anthera-prices-private-stock-offering-1_25-shares-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303349\" data-ts=\"1508852764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303349-bofaml-downgrades-red-hat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML downgrades Red Hat</a></h4><ul><li>        Bank of America Merrill Lynch <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiAytOrsYnXAhVow1QKHY2SAaYQqQIIJSgAMAA&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FBofAMerrill%2BLynch%2BDowngrades%2BRed%2BHat%2B%28RHT%29%2Bto%2BUnderperform%2F13415599.html&amp;usg=AOvVaw1lq6Ga5cHtepP5TbNWWOQr\" target=\"_blank\">downgrades</a> Red Hat (NYSE:<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>) from Neutral to Underperform with a $115 price target.</li><li>                  Analyst Kash Rangan cites valuation concerns.&nbsp;    </li><li>               Red Hat shares are&nbsp;<font color='red'>down 0.82%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300685-alibaba-red-hat-announce-cloud-partnership\" target=\"_blank\">Alibaba, Red Hat announce cloud partnership</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303349\" data-linked=\"BofAML downgrades Red Hat\" data-tweet=\"$RHT - BofAML downgrades Red Hat https://seekingalpha.com/news/3303349-bofaml-downgrades-red-hat?source=tweet\" data-url=\"https://seekingalpha.com/news/3303349-bofaml-downgrades-red-hat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303342\" data-ts=\"1508851762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRTO\" target=\"_blank\">CRTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303342-criteominus-4_2-apple-changes-prompt-downgrade-keybanc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Criteo -4.2% as Apple changes prompt downgrade at KeyBanc</a></h4><ul>   <li>Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>) is <font color='red'>off 4.2%</font> premarket after a downgrade to Sector Weight at Keybanc.</li>    <li>The firm notes Apple's rollout of Intelligent Tracking Prevention in the latest iteration of its operating system will have an outsized impact on revenues, effectively eliminating Criteo's ability to track users in the Safari browser.</li>    <li>That browser drives 20% of revenue for Criteo ex-TAC, and Criteo's workaround doesn't look particularly effective, the firm says. (h/t Bloomberg)</li>    <li>KeyBanc has cut its fair value estimate to $49 from $62 (implying just 6.2% upside) and has trimmed 2017 and 2018 expectations for revenue, EBITDA and EPS.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303342\" data-linked=\"Criteo -4.2% as Apple changes prompt downgrade at KeyBanc\" data-tweet=\"$CRTO - Criteo -4.2% as Apple changes prompt downgrade at KeyBanc https://seekingalpha.com/news/3303342-criteominus-4_2-apple-changes-prompt-downgrade-keybanc?source=tweet\" data-url=\"https://seekingalpha.com/news/3303342-criteominus-4_2-apple-changes-prompt-downgrade-keybanc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303341\" data-ts=\"1508851753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303341-mcdonalds-battles-through-restaurant-sector-pressures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDonald&#39;s battles through restaurant sector pressures</a></h4><ul> <li>McDonald's (NYSE:<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a>) impressed again in Q3 with U.S. comparable sales growth of over 4% during a quarter that saw high population areas of Florida and Texas come to a standstill during the major hurricanes that struck.</li> <li>The solid mark could indicate that some of McDonald's U.S. promotions are generating repeat traffic, note analysts. The extra sales are needed by the restaurant operator due to extra pressure from higher labor wages and elevated commodity costs. In McDonald's <a href=\"https://seekingalpha.com/filing/3735165\" target=\"_blank\">8-K</a>, the restaurant chain disclosed that its Q3 U.S. restaurant margin fell to 15.5% from 16.9% a year ago.</li> <li>Another talking point from the quarter was the accelerated pace of refranchising in China and Hong Kong that has put the initiative \"more than a year ahead of schedule,\" according to CFO Kevin Ozan.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303279-comparable-sales-strong-mcdonalds\" target=\"_blank\">Comparable sales strong at McDonald's</a> (Oct. 24)</li> <li>MCD <font color='green'>+1.02%</font> premarket to $165.01, not that far off from the all-time high of $167.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303341\" data-linked=\"McDonald&#39;s battles through restaurant sector pressures\" data-tweet=\"$MCD - McDonald&#39;s battles through restaurant sector pressures https://seekingalpha.com/news/3303341-mcdonalds-battles-through-restaurant-sector-pressures?source=tweet\" data-url=\"https://seekingalpha.com/news/3303341-mcdonalds-battles-through-restaurant-sector-pressures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303340\" data-ts=\"1508851661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRC\" target=\"_blank\">FRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303340-first-republic-edges-lower-after-another-equity-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Republic edges lower after another equity raise</a></h4><ul><li>The 2M share secondary was upsized to 2.5M shares, and the sale raised gross proceeds of $243.3M, suggesting a price of $97.32 each.</li><li>The underwriters have an option to buy another 375K shares at that price.</li><li><a href='https://seekingalpha.com/symbol/FRC' title='First Republic Bank'>FRC</a>&nbsp;<font color='red'>-0.25%</font>&nbsp;premarket to $99.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16977521-first-republic-bank-prices-common-stock-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303340\" data-linked=\"First Republic edges lower after another equity raise\" data-tweet=\"$FRC - First Republic edges lower after another equity raise https://seekingalpha.com/news/3303340-first-republic-edges-lower-after-another-equity-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3303340-first-republic-edges-lower-after-another-equity-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303338\" data-ts=\"1508851453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLW\" target=\"_blank\">GLW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303338-corningplus-3_8-q3-measures-rise-and-beat-street-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corning +3.8% as Q3 measures rise and beat Street expectations</a></h4><ul>   <li>Corning (NYSE:<a href='https://seekingalpha.com/symbol/GLW' title='Corning Inc.'>GLW</a>) is <font color='green'>up 3.8%</font> and quoting back within pennies of a 52-week high after <a href=\"https://seekingalpha.com/news/3303263-corning-beats-0_02-beats-revenue\" target=\"_blank\">Q3 results</a> where profits and sales rose and beat Y/Y with strong results in its fiber segment.</li>    <li>The company reached 1B km of optical fiber sales during the quarter, and net sales in its Optical Communications segment rose 15% to $917M.</li>    <li>Net income was up 37% Y/Y to $390M on a GAAP basis, and EPS rose 50%. Core earnings dipped 7% to $433M.</li>    <li>GAAP net sales by segment: Display Technologies, $768M (down 15%); Optical Communications, $917M (up 15%); Environmental Technologies, $277M (up 5%); Specialty Materials, $373M (up 26%); Life Sciences, $223M (up 4%).</li>    <li>As for outlook: &ldquo;Year-to-date achievements and fourth-quarter expectations are strong,\" says CFO Tony Tripeny. \"We anticipate that every business segment will meet or beat the plan we set in January due to strong operating performance and early sales from our near-term growth investments.\"</li>    <li><a href=\"https://seekingalpha.com/filing/3735137\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3303338\" data-linked=\"Corning +3.8% as Q3 measures rise and beat Street expectations\" data-tweet=\"$GLW - Corning +3.8% as Q3 measures rise and beat Street expectations https://seekingalpha.com/news/3303338-corningplus-3_8-q3-measures-rise-and-beat-street-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3303338-corningplus-3_8-q3-measures-rise-and-beat-street-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303337\" data-ts=\"1508851407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303337-corbus-pharma-prices-stock-offering-7-shares-down-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corbus Pharma prices stock offering at $7; shares down 6% premarket</a></h4><ul><li>Corbus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) <a href=\"https://seekingalpha.com/pr/16977754-corbus-pharmaceuticals-holdings-inc-prices-underwritten-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 4.65M shares of common stock at $7 per share. Underwriters over-allotment is an additional 697.5K shares. Closing date is October 26. Net proceeds will fund the continued development of anabasum and general corporate purposes.</li><li>Yesterday's close was $7.40.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303337\" data-linked=\"Corbus Pharma prices stock offering at $7; shares down 6% premarket\" data-tweet=\"$CRBP - Corbus Pharma prices stock offering at $7; shares down 6% premarket https://seekingalpha.com/news/3303337-corbus-pharma-prices-stock-offering-7-shares-down-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3303337-corbus-pharma-prices-stock-offering-7-shares-down-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303336\" data-ts=\"1508851267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303336-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+44%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16977286-recon-provide-wastewater-treatment-products-services-totaling-2-million-qinghai-oilfield\" target=\"_blank\">providing</a> chemical compound agents and microbiological treatment agents and relevant services for oily sewage treatments to Qinghai Oilfield Company.</li><li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+20%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3303305-stunning-growth-moviepass\" target=\"_blank\">growth</a> of MoviePass.</li><li><a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+14%</font>&nbsp;on the <a href=\"https://seekingalpha.com/pr/16977185-pain-therapeutics-announces-successful-phase-clinical-study-ptiminus-125\" target=\"_blank\">completion</a> of a Phase I clinical study for PTI-125.</li><li><a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3303222-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li><li><a href='https://seekingalpha.com/symbol/GPK' title='Graphic Packaging Holding Company'>GPK</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3303236-ip-graphic-packaging-higher-transformational-deal\" target=\"_blank\">transformational</a> deal with&nbsp;&nbsp;International Paper (NYSE:<a href='https://seekingalpha.com/symbol/IP' title='International Paper Co.'>IP</a>).</li><li><a href='https://seekingalpha.com/symbol/PII' title='Polaris Industries Inc.'>PII</a> <font color='green'>+6%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3303179-polaris-beats-0_23-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+6%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3303251-caterpillar-beats-0_68-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='green'>+5%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3303234-fda-oks-expanded-use-alexions-soliris-shares-6-percent-premarket\" target=\"_blank\">approved</a> expanded use of Alexion's Soliris.</li><li><a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+5%</font>&nbsp;as VK2809 <a href=\"https://seekingalpha.com/news/3303299-viking-therapeutics-vk2809-shows-positive-effect-nash-model-shares-ahead-9-percent-premarket\" target=\"_blank\">shows</a> positive effect in NASH model.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303336\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$RCON $HMNY $SAVA - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3303336-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3303336-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303333\" data-ts=\"1508851160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DEST\" target=\"_blank\">DEST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303333-destination-maternity-tracking-higher-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Destination Maternity tracking higher again</a></h4><ul> <li>Destination Maternity (NASDAQ:<a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a>) is volatile in the premarket session.</li> <li>Shares crossed over the $3 mark for the first time since July with a&nbsp;<font color='green'>4.5% premarket push</font>&nbsp;higher and are now up about 88% over the last five trading sessions.</li> <li>Last week, the maternity apparel seller reported Q3 e-commerce sales growth to date of over 50%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303333\" data-linked=\"Destination Maternity tracking higher again\" data-tweet=\"$DEST - Destination Maternity tracking higher again https://seekingalpha.com/news/3303333-destination-maternity-tracking-higher-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3303333-destination-maternity-tracking-higher-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303330\" data-ts=\"1508851096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTIE\" target=\"_blank\">PTIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303330-pain-therapeutics-alzheimers-candidate-ptiminus-125-shows-encouraging-action-in-early-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pain Therapeutics&#39; Alzheimer&#39;s candidate PTI-125 shows encouraging action in early-stage study; shares ahead 14% premarket</a></h4><ul><li>Thinly traded nano cap Pain Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a>) is up&nbsp;<font color='green'>14%</font>&nbsp;premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16977185-pain-therapeutics-announces-successful-phase-clinical-study-ptiminus-125\" target=\"_blank\">announcement </a>of positive results from a Phase 1 study assessing Alzheimer's disease &#40;AD&#41; candidate PTI-125.</li><li>The data from 24 healthy volunteers showed PTI-125 was safe and well-tolerated at all doses studied and showed a favorable pharmacokinetic profile for further development.</li><li>Small molecule PTI-125 binds to a protein that plays an essential role in beta amyloid's toxicity called filamin A. The company says binding to filamin A prevents and even reverses amyloid-related AD damage.</li><li>Pain is also working on a diagnostic blood test for AD supported by a $1.8M grant from NIH.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303330\" data-linked=\"Pain Therapeutics&#39; Alzheimer&#39;s candidate PTI-125 shows encouraging action in early-stage study; shares ahead 14% premarket\" data-tweet=\"$PTIE $SAVA - Pain Therapeutics&#39; Alzheimer&#39;s candidate PTI-125 shows encouraging action in early-stage study; shares ahead 14% premarket https://seekingalpha.com/news/3303330-pain-therapeutics-alzheimers-candidate-ptiminus-125-shows-encouraging-action-in-early-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3303330-pain-therapeutics-alzheimers-candidate-ptiminus-125-shows-encouraging-action-in-early-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303326\" data-ts=\"1508850871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303326-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a>&nbsp;<font color='red'>-26%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3303084-hni-beats-0_02-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16977467-anthera-pharmaceuticals-announces-pricing-15-million-private-placement-offering\" target=\"_blank\">announcing</a> pricing of $15M private placement offering.</li><li><a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3303304-immune-design-readies-16m-share-stock-offering-shares-13-percent-premarket\" target=\"_blank\">announcing</a> proposed public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a>&nbsp;<font color='red'>-10%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3303098-whirlpool-slumps-guidance-cut\" target=\"_blank\">guidance</a> cut.</li><li><a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>&nbsp;<font color='red'>-6%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3303062-corbus-pharma-readies-stock-offering-shares-23-percent-hours\" target=\"_blank\">announcing</a>&nbsp;proposed public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>&nbsp;<font color='red'>-6%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3303233-interpublic-group-companies-misses-0_02-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3303326\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$HNI $ANTH $IMDZ - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3303326-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3303326-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303317\" data-ts=\"1508850269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303317-gileads-gsminus-0976-shows-positive-effect-in-mid-stage-nash-study-shares-ahead-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead&#39;s GS-0976 shows positive effect in mid-stage NASH study; shares ahead 1% premarket</a></h4><ul><li>Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) perks up&nbsp;<font color='green'>1%&nbsp;</font>premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16977493-gilead-announces-phase-2-results-gsminus-0976-nonalcoholic-steatohepatitis-nash\" target=\"_blank\">announcement </a>of positive results from a 126-subject Phase 2 clinical trial assessing GS-0976, an oral inhibitor of Acetyl-CoA carboxylase &#40;ACC&#41;, in patients with nonalcoholic steatohepatitis &#40;NASH&#41;. The data are being presented at The Liver Meeting in Washington, D.C.</li><li>Patients receiving the higher dose (20 mg once daily) of GS-0976 for 12 weeks experienced statistically significant reductions in hepatic steatosis (buildup of fat in the liver) and TIMP-1 ( a marker of fibrosis) compared to placebo.</li><li>ACC plays a key role in several pathways associated with the progression of NASH. Specifically, it catalyzes the first step in the synthesis of fatty acids that contribute to hepatic steatosis, leading to inflammation and liver fibrosis.</li><li>The development of GS-0976 is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303317\" data-linked=\"Gilead&#39;s GS-0976 shows positive effect in mid-stage NASH study; shares ahead 1% premarket\" data-tweet=\"$GILD - Gilead&#39;s GS-0976 shows positive effect in mid-stage NASH study; shares ahead 1% premarket https://seekingalpha.com/news/3303317-gileads-gsminus-0976-shows-positive-effect-in-mid-stage-nash-study-shares-ahead-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3303317-gileads-gsminus-0976-shows-positive-effect-in-mid-stage-nash-study-shares-ahead-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}